Clinical trials: Intestinal Mucositis
Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine)
TRIAD Burden of Illness Mucositis Study
Observational (non-drug) study to look at the risks and burden of mucositis (sores) involving the mouth, throat and intestines in patients receiving chemotherapy and radiation therapy treatment for various cancer types.
- Trial name
- NCT00336609
- Where
- United States
- Volunteers
- 1,600 people
- Sponsor
- TRIAD Burden of Illness
Colon Cancer, Oral Mucositis
The Effects of Ankaferd Blood Stopper
The purpose of oral care is to reduce the effect of oral pathological microbial flora and to prevent infection, pain, and bleeding associated with cancer treatment.
- Conditions
- Colon Cancer, Oral Mucositis, Nurse's Role, Chemotherapy Effect
- Trial name
- ABS (NCT05438771)
- Testing
- Ankaferd Blood Stopper, Bicarbonate
- Where
- Turkey (Türkiye)
- Volunteers
- 66 people
- Sponsor
- Uludag University
Colo-rectal Cancer
Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy
Introduction: In the 2023-2025 period, colorectal cancer (CRC) will be the third most common type of cancer in Brazil. The most commonly used therapeutic approaches are chemotherapy (QTx) and radiotherapy (RTx).
- Trial name
- NCT06576986
- Testing
- Symbiotic, Maltodextrin
- Where
- Brazil
- Volunteers
- 80 people
- Sponsor
- Federal University of Minas Gerais
Inflammatory Bowel Diseases, Mucosal Inflammation
Phase Angle and Chronic Intestinal Inflammatory Diseases
Phase angle (PhA) is a biometric parameter measured by bioimpedance analysis (BIA), which reflects organism cellularity and tissues hydration.
- Conditions
- Inflammatory Bowel Diseases, Mucosal Inflammation, Leukocyte L1 Antigen Complex, C-Reactive Protein
- Trial name
- PHIBO (NCT05106738)
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- University of Bari
Colorectal Cancer
Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis
Colorectal cancer (CRC) represents one of the most common cancers worldwide and 5-Fluorouracil (5-FU) is still the mainstay of treatment.
- Trial name
- NCT07736495
- Testing
- alpha lipoic acid 600 mg twice daily
- Where
- Egypt
- Volunteers
- 50 people
- Sponsor
- Ain Shams University